Skip to main content
Year archive

Thiogenesis Therapeutics, Corp. — 2020 filings

All 17 regulatory filings released by Thiogenesis Therapeutics, Corp. (TTI) in 2020, sourced directly from the official regulator.

17 Filings
2020 Period
2020 filings (17)
Filing Released Lang
Material change report - English.pdf
Regulatory Filings
2020-11-04 English
News release - English.pdf
M&A Activity
2020-11-02 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report H1 2021
2020-10-21 English
Interim MD&A - English.pdf
Interim / Quarterly Report H1 2021
2020-10-21 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2020-10-21 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2020-10-21 English
Interim MD&A - English.pdf
Regulatory Filings
2020-07-16 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2020-07-16 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2020-07-16 English
Interim financial statements/report – English.pdf
Regulatory Filings
2020-07-16 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2020-06-22 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2020-06-22 English
Annual MD&A - English.pdf
Management Reports
2020-06-22 English
Interim financial statements/report – English.pdf
Regulatory Filings
2020-01-24 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2020-01-24 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2020-01-24 English
Interim MD&A - English.pdf
Management Reports
2020-01-24 English